Article
BARRONS
(2020)
The company said it is sponsoring a 400-patient randomized trial to confirm whether the drug Olumiant can moderate Covid symptoms.
—-
“... The idea that Eli Lilly ’s arthritis drug Olumiant might help Covid-19 patients emerged from an artificial-intelligence survey of approved drugs...
Summit
updated 7 days ago
Comments
Related Chunks
Related chunks with this resource
Artificial intelligence AI and drug research, medicine and health care
RELATED RESOURCES
with chunks in common
2017
a16z Podcast: Putting AI in Medicine, in Practice – Andreessen Horowitz
Saved by: Summit
3 chunks
2019
Making New Drugs With a Dose of Artificial Intelligence - The New York Times
Saved by: Summit
2 chunks
2019
Elon Musk’s brain-interface company is promising big news. Here’s what it could be. - MIT Technology Review
Saved by: Summit
2 chunks
2020
Fast-moving Regeneron eyes summer clinical trial for COVID-19 antibody cocktail therapy
Saved by: Summit
1 chunk
2020
Machine Learning Company Insitro Raises $143 Million To Bridge Biology And AI
Saved by: Summit
2 chunks
2020
A drug that cools the body’s reaction to Covid-19 appears to save lives
Saved by: Summit
1 chunk
2020
Inexpensive steroids reduce deaths of hospitalized Covid-19 patients, WHO analysis confirms
Saved by: Summit
1 chunk
No comments yet. Be the first to comment!